Indirect benefits are a crucial consideration when evaluating SARS-CoV-2 vaccine candidates
- 23 November 2020
- journal article
- letter
- Published by Springer Nature in Nature Medicine
- Vol. 27 (1) , 4-5
Abstract
No abstract availableKeywords
All Related Versions
This publication has 7 references indexed in Scilit:
- DNA vaccine protection against SARS-CoV-2 in rhesus macaquesScience, 2020
- Considering indirect benefits is critical when evaluating SARS-CoV-2 vaccine candidatesmedRxiv, 2020
- Human Challenge Studies to Accelerate Coronavirus Vaccine LicensureThe Journal of Infectious Diseases, 2020
- Direct and indirect effects of influenza vaccinationBMC Infectious Diseases, 2017
- Optimizing Influenza Vaccine DistributionScience, 2009
- Study Designs for Dependent HappeningsEpidemiology, 1991
- FIELD-EVALUATION OF VACCINE EFFICACY1985